Historical record - last NADAC publication: 3/18/2020
Product Information
ABREVA 10% CREAM is a brand product labeled by Haleon US Holdings LLC, priced at $8.1199 per GM under NDC 00135020005. Its NADAC has been published 132 times since Dec 27, 2017.
The High Outlier badge above means this manufacturer's average price in the docosanol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/g
Manufacturer
Haleon US Holdings LLCNDC
00135020005
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Last Updated
3/18/2020
Active Ingredients
DOCOSANOLApproval Type
New Drug (NDA)
FDA Application
NDA020941On Market Since
3/19/2010
Price Statistics
The NADAC for ABREVA 10% CREAM has been published 132 times since Dec 27, 2017, and over the history we have for it it has risen 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1199 per GM |
|---|---|
| All-time high | $8.2225 (Mar 11, 2020) |
| All-time low | $7.6536 (Mar 21, 2018) |
| Median price | $7.8669 |
| Average price | $7.9709 |
| Largest weekly change | +4.4% (Apr 17, 2019) |
| Weeks tracked | 132 |
| Tracking since | Dec 27, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABREVA 10% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for ABREVA 10% CREAM, manufactured by Haleon US Holdings LLC, is $8.1199 per GM (NDC 00135020005), effective Jul 1, 2020.
How has the price of ABREVA 10% CREAM changed over time?
Over the history we have for it, the NADAC for ABREVA 10% CREAM has risen 3.2%. It has been tracked across 132 weekly CMS publications since Dec 27, 2017.
What are the highest and lowest recorded NADAC prices for ABREVA 10% CREAM?
Since Dec 27, 2017, the NADAC for ABREVA 10% CREAM has ranged from a low of $7.6536 (Mar 21, 2018) to a high of $8.2225 (Mar 11, 2020), with a median of $7.8669 per GM.
Are there cheaper alternatives to ABREVA 10% CREAM?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ABREVA 10% CREAM, but none are currently priced below it.
Who manufactures ABREVA 10% CREAM?
ABREVA 10% CREAM (NDC 00135020005) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification